Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  Pyridine compound >  Ethylpyridine >  5-BROMO-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER

5-BROMO-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER

Basic information Safety Supplier Related

5-BROMO-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER Basic information

Product Name:
5-BROMO-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER
Synonyms:
  • 5-Bromo-pyrazolo[1,5-a]pyridine-3-carboxylate ethyl ester
  • Ethyl 5-broMopyrazolo[1,5-a]pyridine-3-carboxylate
  • Ethyl 5-broMopyrazolo[1,5...
  • ethyl 5-broMoH-pyrazolo[1,5-a]pyridine-3-carboxylate
  • 5-BroMo-1H-pyrazolo[1,5-a]pyridin-3-carboxylic acid ethyl ester
  • Pyrazolo[1,5-a]pyridine-3-carboxylic acid, 5-broMo-, ethyl ester
  • 5-Bromopyrazolo[1,5-a]pyridin-3-carboxylic acid ethyl ester
  • 5-bromo-3-pyrazolo[1,5-a]pyridinecarboxylic acid ethyl ester
CAS:
885276-93-7
MF:
C10H9BrN2O2
MW:
269.09
EINECS:
200-258-5
Product Categories:
  • Heterocycle-Pyridine series
Mol File:
885276-93-7.mol
More
Less

5-BROMO-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER Chemical Properties

Density 
1.60±0.1 g/cm3(Predicted)
storage temp. 
Sealed in dry,Room Temperature
pka
-0.16±0.30(Predicted)
Appearance
White to off-white Solid
InChI
InChI=1S/C10H9BrN2O2/c1-2-15-10(14)8-6-12-13-4-3-7(11)5-9(8)13/h3-6H,2H2,1H3
InChIKey
LJKZKCQPVABNLG-UHFFFAOYSA-N
SMILES
C12=C(C(OCC)=O)C=NN1C=CC(Br)=C2
More
Less

5-BROMO-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTER Usage And Synthesis

Synthesis

1533440-88-8

623-47-2

885276-93-7

General procedure for the synthesis of ethyl 5-bromopyrazolo[1,5-a]pyridine-3-carboxylate from 1-amino-4-bromopyridinium iodide and ethyl propargylate: To a 250 mL three-necked round-bottomed flask was added 1-amino-4-bromopyridinium iodide (Compound 64.2, 15 g, ca. 50% purity, 24.9 mmol) in N,N-dimethylformamide (80 mL) Solution. Potassium carbonate (10.6 g, 76.7 mmol) was added batchwise, followed by ethyl propargylate (11.7 mL, 115 mmol) dropwise over 10 min. The reaction mixture was stirred overnight at room temperature and then diluted with ethyl acetate (300 mL) and water (100 mL). Insoluble solids were removed by filtration, and the organic layer was washed with saturated saline (3 x 50 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography using ethyl acetate/petroleum ether (1:10) as eluent to afford ethyl 5-bromopyrazolo[1,5-a]pyridine-3-carboxylate as a brown solid (300 mg, 6% yield).

References

[1] Patent: WO2014/8197, 2014, A1. Location in patent: Page/Page column 135
[2] Patent: WO2015/95767, 2015, A1. Location in patent: Page/Page column 150

5-BROMO-PYRAZOLO[1,5-A]PYRIDINE-3-CARBOXYLIC ACID ETHYL ESTERSupplier

JW & Y Pharmlab Co., Ltd. Gold
Tel
021-64340559 13651849907;
Email
xinyu_shi@jwypharmlab.com.cn
Shanghai Huiyu Biological Technology Co., LTD Gold
Tel
17280940401
Email
huiyu_bio@126.com
ChengDu TongChuangYuan Pharmaceutical Co.Ltd Gold
Tel
028-83379370 13880556291
Email
tcy@tcypharm.com
Jinan Kabotang Biological Technology Co.,Ltd. Gold
Tel
0531-61320525 15866703830
Email
figo.gao@foxmail.com
Shandong Boda Pharmaceutical Co., Ltd Gold
Tel
15624526479 15624526479
Email
18678253918@163.com